Lee Kalowski

Companies

• Q32 Bio Inc.Chief financial officer Mar 27, 2024 to now¹
• Q32 Bio Inc.President Mar 27, 2024 to now¹
• Bicycle Therapeutics (United Kingdom)Chief financial officer May 22, 2019 to Apr 5, 2023²
• Bicycle Therapeutics (United Kingdom)President May 22, 2019 to Apr 5, 2023²
• Eledon Pharmaceuticals, Inc.Chief financial officer Sep 16, 2014 to Dec 17, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• QBQ32 Bio Inc. QTTB138,471 shares⁴$1.1M at $7.77Aug 25, 2026
• Bicycle Therapeutics (United Kingdom) BCYC30,309 shares⁵$104.9K at $3.46Apr 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 25, 2026Sold 3,972 shares at $16.56 of Q32 Bio Inc.⁴
• Jul 16, 2026Granted 53,250 shares of Q32 Bio Inc.⁶
• Feb 25, 2026Sold 3,995 shares at $4.51 of Q32 Bio Inc.⁷
• Feb 24, 2026Granted 53,250 shares of Q32 Bio Inc.⁸
• Dec 2, 2025Sold 9,072 shares at $3.46 of Q32 Bio Inc.⁹
• Aug 26, 2025Sold 4,240 shares at $1.80 of Q32 Bio Inc.¹⁰
• Feb 24, 2025Granted 53,250 shares of Q32 Bio Inc.¹¹
• Apr 3, 2023Sold 376 shares at $21.11 of Bicycle Therapeutics (United Kingdom)⁵
• Jan 3, 2023Sold 1,815 shares at $29.06 of Bicycle Therapeutics (United Kingdom)¹²
• Jan 3, 2023Granted 17,500 shares of Bicycle Therapeutics (United Kingdom)¹²
• Jan 3, 2022Granted 15,000 shares of Bicycle Therapeutics (United Kingdom)¹³